Understanding the many different genetic causes of childhood-onset hearing loss suggests that genomic testing could aid in treatment planning, including optimal treatment timing.
An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce
The Institute of Psychiatry, Psychology, and Neuroscience (IoPPN) at King's College London has developed a blood-based test that can predict the risk of Alzheimer's disease up to 3.5 years before clinical diagnosis.
A recent study discovered that population-based genomic screening can help in the early diagnosis of medullary thyroid cancer (MTC) in patients with RET gene variations.
Even though the syndrome is a rare condition, it has a significant death rate, with up to 50 per cent of sufferers--mostly men--passing away within five years of diagnosis
Understanding the many different genetic causes of childhood-onset hearing loss suggests that genomic testing could aid in treatment planning, including optimal treatment timing.
Advances in understanding the diverse genetic causes of childhood-onset hearing loss suggest that genomic testing could help with treatment planning, including appropriate therapy timing.
Advances in understanding the many different genetic causes of childhood-onset hearing loss indicate that genomic testing could assist in treatment planning, including optimal timing of treatment.
In a new study, U.S. and Danish researchers report that patients hospitalized with Lyme disease had a 28 per cent higher rate of mental disorders and were twice as likely to have attempted suicide post-infection, compared to individuals without the diagnosis.
According to the findings of a study led by UC San Francisco, the progression of a low-grade, slow-growing brain tumour to a deadly one can be delayed if neurosurgeons remove as much as possible soon after diagnosis.
New Delhi [India], January 5 (ANI/SRV): Surat Hematology Centre makes blood cancer diagnosis possible for the people of Surat and South Gujarat for the first time ever. This feat was made possible by the Surat Hematology Centre with the help of ABHA Lab. The centre had to work hard to make t
MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far-flung areas.